Lv11
30 积分 2024-06-27 加入
Efficacy and Safety of Daratumumab-based Regimens in Pretreated Light Chain (AL) Amyloidosis: A Systematic Review
14天前
已完结
VEGF及其促肿瘤血管形成作用的研究进展
3个月前
已完结
230MO Pembrolizumab plus anlotinib as first-line treatment in patients of CPS≥1 with recurrent or metastatic head and neck squamous-cell carcinoma: A prospective phase II study
4个月前
已完结
Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial
4个月前
已完结
Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial
4个月前
已完结
Ramucirumab in combination with pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma: a single-centre, phase 1/2 trial
4个月前
已完结
卵巢衰老的机制与治疗策略
4个月前
已完结
卵巢囊肿
4个月前
已完结
强直性脊柱炎诊疗规范
5个月前
已完结
皖公网安备34019202002308
